🔴 Opus Genetics is trading 5% down in after-hours trading — no confirmed company-specific catalyst

Opus Genetics is trading 5.29% down at $3.28 after hours on October 27, 2026, with no identified company-specific explanation.

• Shares gained 4.22% during the regular session to $3.46, while the supplied market context showed major U.S. indexes higher.
• The latest developments identified were the October 21 FDA clearance of an investigational gene-therapy application and an investor discussion of the pipeline and projected cash runway; neither was reported as a direct cause.